GO:1903496 response to 11-deoxycorticosterone: Steroid Stress Response, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1903496 (response to 11-deoxycorticosterone) is a biological_process describing any change in cell or organism state caused by an 11-deoxycorticosterone stimulus.
• 11-deoxycorticosterone (DOC) is a mineralocorticoid precursor whose effects span electrolyte handling, blood pressure regulation, immune-endocrine crosstalk, and stress-responsive transcription.
• Transcriptomic studies in rainbow trout skeletal muscle show DOC modulates stress-responsive gene expression programs, linking this GO term to cortisol-independent stress biology.
• In mammals, DOC and its 18-hydroxylated metabolite are dynamically regulated by ACTH, insulin, sodium intake, and furosemide, making the response context-dependent.
• DOC excess is experimentally modeled by DOCA-salt protocols, a classic hypertension model that connects this GO term to cardiovascular disease research.
• Studying GO:1903496 benefits from CRISPR knockout, knock-in, overexpression, and library screening to dissect causal genes in the DOC response pathway.
Description
GO:1903496, response to 11-deoxycorticosterone, is a Gene Ontology biological_process term that captures any process resulting in a change in state or activity of a cell or an organism in response to an 11-deoxycorticosterone stimulus. 11-deoxycorticosterone (DOC) is a steroid intermediate in the mineralocorticoid and glucocorticoid biosynthetic pathways, and its biological actions extend beyond classical electrolyte regulation to include stress-axis modulation and immune-endocrine integration. Because DOC sits at a metabolic branch point, the cellular response to it is pleiotropic and context-dependent, which makes GO:1903496 a useful annotation for studies spanning endocrinology, cardiovascular biology, and comparative stress physiology. Researchers annotate genes and gene products to GO:1903496 when experimental evidence shows that a DOC stimulus alters their expression, secretion, movement, or enzymatic activity. This term is therefore central to interpreting transcriptomic and physiological datasets in which DOC is administered in vivo or applied to cells. For example, DOC treatment alters the transcriptomic response to stress in rainbow trout skeletal muscle, demonstrating that the term applies across vertebrate taxa and to non-classical target tissues. In mammals, the response to DOC is shaped by ACTH, insulin, sodium status, and diuretic challenge, indicating that the term encompasses both direct steroid actions and upstream regulatory inputs. Understanding GO:1903496 matters because DOC is both an endogenous hormone and an experimental tool. Its excess produces DOCA-salt hypertension in rodents, a widely used model of mineralocorticoid-driven cardiovascular pathology. At the same time, DOC modulates immune and endocrine variables in fish, illustrating conserved stress-related functions. This article synthesizes the QuickGO definition with verified PubMed literature to provide a research-grade overview of the mechanisms, genes, disease links, and CRISPR-based methods relevant to response to 11-deoxycorticosterone.
response to 11-deoxycorticosterone At A Glance
| GO ID | GO:1903496 |
|---|---|
| GO term | response to 11-deoxycorticosterone |
| Ontology | biological_process |
| Synonym | none listed in QuickGO |
| Definition | Any process that results in a change in state or activity of a cell or an organism as a result of an 11-deoxycorticosterone stimulus. |
| Major function | Mediates cellular and systemic responses to the steroid 11-deoxycorticosterone, including transcriptional, secretory, and electrolyte-handling changes. |
| Stimulus | 11-deoxycorticosterone (DOC), a mineralocorticoid/glucocorticoid precursor steroid. |
| Taxonomic scope | Annotated across vertebrates, including mammals and teleost fish. |
| Related physiology | Electrolyte balance, blood pressure regulation, stress response, immune-endocrine crosstalk. |
| Experimental models | DOCA-salt hypertension, ACTH/insulin/furosemide challenge, LPS immune challenge, transcriptomic stress assays. |
What Is GO:1903496?
In our own words, GO:1903496 describes the full set of cellular and organismal changes triggered by exposure to 11-deoxycorticosterone. These changes can include altered gene expression, modified secretion of hormones or electrolytes, changes in cell movement, and shifts in enzyme production. The term is deliberately broad: it covers any downstream process that is initiated or modified because a cell or organism sensed DOC. It does not specify a single receptor or pathway, so annotations can include mineralocorticoid receptor-dependent transcription, electrolyte transport responses, and stress-axis feedback events, provided the DOC stimulus is the causal trigger.
Why Is response to 11-deoxycorticosterone Important in Cell Biology?
GO:1903496 is important because 11-deoxycorticosterone is a bioactive steroid at the intersection of mineralocorticoid and glucocorticoid biology, and its response pathways influence blood pressure, electrolyte homeostasis, stress adaptation, and immune function. Experimental DOC excess produces DOCA-salt hypertension, a foundational model for studying mineralocorticoid-driven cardiovascular disease. In normal human physiology, DOC and its 18-hydroxylated metabolite respond dynamically to ACTH, insulin, furosemide, and sodium intake, showing that the response is tightly regulated and clinically relevant. Comparative studies in fish demonstrate that DOC also modulates immune and endocrine variables during stress, indicating deep evolutionary conservation of this response process. For researchers, annotating genes to GO:1903496 provides a principled way to connect steroid exposure to downstream molecular phenotypes and to prioritize causal candidates for CRISPR validation.
• Provides a standardized ontology annotation for studies using 11-deoxycorticosterone as a stimulus.
• Links DOC exposure to transcriptomic stress responses in skeletal muscle and other tissues.
• Connects steroid biology to electrolyte and urine electrolyte handling in normal human subjects.
• Supports research on mineralocorticoid-driven hypertension through the DOCA-salt model.
• Explains context-dependent regulation of DOC and 18-hydroxy-DOC by ACTH, insulin, and sodium status.
• Highlights immune-endocrine crosstalk, as DOC modulates LPS-induced responses in fish.
• Enables cross-species comparisons of steroid stress responses in vertebrates.
• Guides CRISPR knockout and knock-in design for genes hypothesized to mediate DOC responses.
• Helps interpret urinary kallikrein and electrolyte data in salt-sensitive hypertension models.
• Supports biomarker discovery for mineralocorticoid excess and related cardiovascular conditions.
What Happens During response to 11-deoxycorticosterone?
Stimulus recognition and steroid entry
In simple terms: The cell first encounters the steroid 11-deoxycorticosterone, which can act at the cell surface or enter the cell to engage intracellular receptors.
The response begins when 11-deoxycorticosterone reaches a target cell or organism. Because DOC is a lipophilic steroid, it can diffuse across membranes and engage intracellular receptors, while membrane-associated signaling may also contribute. In vivo, the effective DOC stimulus depends on circulating levels, which are themselves regulated by ACTH, insulin, sodium intake, and diuretic status. Experimental administration of DOC or its 18-hydroxylated form produces measurable physiological responses in normal human subjects, confirming that the stimulus is sufficient to initiate the process. In rainbow trout, DOC treatment alters the transcriptomic response to stress in skeletal muscle, showing that stimulus recognition occurs in non-classical target tissues as well.
Transcriptional reprogramming
In simple terms: Once the cell senses the steroid, it changes which genes are turned on or off.
A central component of GO:1903496 is altered gene expression. DOC exposure changes the transcriptomic landscape, as demonstrated in rainbow trout skeletal muscle where DOC modulates the response to stress. This transcriptional reprogramming can affect stress-responsive genes, metabolic enzymes, and signaling components. In mammals, the response to DOC is influenced by the hypothalamic-pituitary-adrenal axis, since ACTH suppression alters the sensitivity of DOC and 11-deoxycortisol to subsequent ACTH stimulation. These findings indicate that transcriptional and endocrine feedback layers are integrated within the response process.
Electrolyte and secretory responses
In simple terms: The steroid can change how the body handles salt and water, and how much of certain substances are excreted.
DOC is a mineralocorticoid precursor, and its response includes changes in electrolyte handling. In normal man, urine electrolyte excretion responds to 18-hydroxy-11-deoxycorticosterone administration, providing direct evidence that the DOC-related steroid stimulus alters renal electrolyte output. In Dahl salt-sensitive rats, the urinary kallikrein response to deoxycorticosterone is anomalous, linking the DOC response to renal enzyme secretion and salt sensitivity. These secretory and transport changes are core physiological outputs of GO:1903496.
Immune-endocrine integration
In simple terms: The steroid response can also change how the immune system reacts to challenges like infection signals.
The response to 11-deoxycorticosterone is not limited to classical mineralocorticoid targets. In Eurasian perch, DOC modulates the in vivo response of immune and endocrine variables to lipopolysaccharide (LPS), indicating that DOC can shape immune-endocrine crosstalk during an inflammatory challenge. This integration means that GO:1903496 annotations may include immune-related genes and cytokines whose expression changes when DOC is present during an immune stimulus.
Cardiovascular and blood pressure outcomes
In simple terms: When the steroid response is sustained or excessive, it can raise blood pressure and drive cardiovascular changes.
Chronic DOC excess is used experimentally to produce DOCA-salt hypertension, a model in which the pathogenesis involves mineralocorticoid effects, salt loading, and downstream cardiovascular remodeling. This outcome links GO:1903496 to blood pressure regulation and cardiovascular pathology. The response process therefore includes not only acute signaling and transcription but also longer-term physiological adaptation that can become maladaptive under sustained steroid exposure.
Key Genes Involved in GO:1903496 response to 11-deoxycorticosterone
The following genes and proteins are relevant to studying response to 11-deoxycorticosterone, based on the physiological and transcriptomic processes documented in the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NR3C2 | Mineralocorticoid receptor mediating DOC-type steroid signaling | Candidate for CRISPR knockout to test DOC response causality |
| POMC | Precursor of ACTH, which regulates DOC levels | Links pituitary control to DOC response |
| CYP11B1 | Enzyme producing 11-deoxycortisol and related steroids | Steroidogenic node upstream of DOC |
| CYP11B2 | Aldosterone synthase acting on DOC as substrate | Connects DOC to mineralocorticoid synthesis |
| INS | Insulin regulates 18-hydroxy-DOC response | Endocrine input to DOC response |
| KLK1 | Kallikrein enzyme measured in urine after DOC | Renal response marker in salt-sensitive models |
| HSPA1A | Stress-inducible chaperone | Stress transcriptome readout after DOC |
| FOS | Immediate early transcription factor | Stress-responsive gene in DOC-treated muscle |
| JUN | Immediate early transcription factor | Stress-responsive gene in DOC-treated muscle |
| IL6 | Inflammatory cytokine | Immune-endocrine crosstalk with DOC |
| TNF | Inflammatory cytokine | Immune response modulated by DOC |
| NR3C1 | Glucocorticoid receptor | Cross-talk with DOC signaling |
| SCNN1A | Epithelial sodium channel subunit | Electrolyte transport downstream of mineralocorticoid signaling |
| ATP1A1 | Sodium-potassium ATPase | Electrolyte homeostasis in DOC response |
| REN | Renin | Blood pressure axis interacting with DOC |
| ACE | Angiotensin-converting enzyme | Cardiovascular axis in DOCA-salt model |
| AGTR1 | Angiotensin II receptor | Blood pressure regulation in DOC excess |
How Is response to 11-deoxycorticosterone Regulated?
The response to 11-deoxycorticosterone is regulated at multiple levels. Upstream, ACTH controls the synthesis and sensitivity of DOC and 11-deoxycortisol, and ACTH suppression alters their responsiveness to stimulation. Insulin also modulates 18-hydroxy-11-deoxycorticosterone levels in normal man, indicating metabolic regulation of the DOC axis. Sodium intake is a key regulator: low sodium intake enhances the sensitivity of 11-deoxycortisol and deoxycorticosterone to ACTH in ACTH-suppressed normal subjects. Furosemide administration, which alters sodium and volume status, also affects 18-hydroxy-11-deoxycorticosterone response. In the DOCA-salt model, dietary salt loading is a required co-factor for the full hypertensive phenotype, showing that the response to DOC is gated by electrolyte environment. Finally, immune challenge with LPS can modulate endocrine variables in the presence of DOC, indicating that inflammatory state is another regulatory layer.
response to 11-deoxycorticosterone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NR3C2 | Mineralocorticoid hypertension | CRISPR knockout in renal or vascular cells |
| KLK1 | Salt-sensitive hypertension | Knock-in of variant in Dahl rat background |
| CYP11B2 | Adrenal steroid dysregulation | Point mutation to alter enzyme activity |
| REN | DOCA-salt hypertension | Overexpression or knockout in rodent models |
| IL6 | Immune-endocrine crosstalk | Knockout in fish or mammalian immune cells |
Mineralocorticoid-driven hypertension
Excess 11-deoxycorticosterone activity is experimentally modeled by DOCA-salt hypertension, a well-established rodent model of mineralocorticoid hypertension. In this model, DOC administration combined with high salt intake produces sustained blood pressure elevation and cardiovascular remodeling. The pathogenesis involves renal sodium retention, vascular changes, and neuroendocrine feedback. Genes annotated to GO:1903496 may therefore contribute to hypertension susceptibility, and the urinary kallikrein response to deoxycorticosterone is anomalous in Dahl salt-sensitive rats, a genetic model of salt-sensitive hypertension.
Essential hypertension and adrenal steroid dysregulation
In essential hypertensive patients, 18-hydroxy-11-deoxycorticosterone responds to ACTH, insulin, and furosemide administration, suggesting that adrenal steroid responsiveness may be altered in human hypertension. This connects GO:1903496 to clinical research on adrenal steroid intermediates as biomarkers or mediators of blood pressure dysregulation. The dynamic responses observed in patients indicate that the DOC response process is not static and can be probed with endocrine challenge tests.
Stress-related and immune-endocrine disorders
DOC modulates the transcriptomic response to stress in rainbow trout skeletal muscle, linking GO:1903496 to stress biology. In Eurasian perch, DOC modulates immune and endocrine responses to LPS, indicating a role in immune-endocrine integration that may be relevant to stress-related and inflammatory conditions. These comparative findings suggest that the DOC response process is conserved and may inform research on stress-related disorders across vertebrates.
From response to 11-deoxycorticosterone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for DOC-induced transcription? | CRISPR knockout cell line plus DOC treatment and RNA-seq |
| Does a specific amino acid change alter DOC responsiveness? | Point-mutation knock-in of the candidate residue |
| Does overexpression of a gene mimic DOC response? | CRISPR knock-in of a constitutive or inducible promoter |
| Where is the protein after DOC stimulation? | Tagged knock-in with fluorescent or epitope tag |
| Which genes mediate DOCA-salt hypertension? | In vivo knockout or knock-in in rodent DOCA-salt model |
| Which pathways respond to DOC in fish muscle? | CRISPR knockout in fish cell lines plus transcriptomics |
How to Study the response to 11-deoxycorticosterone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global transcript changes after DOC | Define DOC response signature |
| ACTH stimulation test | Adrenal steroid responsiveness | Assess DOC axis regulation |
| Insulin tolerance test | 18-hydroxy-DOC response to insulin | Metabolic regulation of DOC |
| Furosemide challenge | Renin-angiotensin-aldosterone axis response | Hypertension research |
| Urine electrolyte assay | Renal electrolyte excretion after steroid | Mineralocorticoid activity |
| Urinary kallikrein assay | Renal kallikrein secretion | Salt-sensitive hypertension |
| LPS immune challenge | Immune-endocrine variables with DOC | Immune crosstalk |
| DOCA-salt protocol | Blood pressure and cardiovascular remodeling | Hypertension model |
Transcriptomic profiling
RNA-seq is a primary method for studying GO:1903496 because the response involves gene expression changes. In rainbow trout skeletal muscle, DOC treatment altered the transcriptomic response to stress, demonstrating that RNA-seq can identify genes whose expression is DOC-dependent. Researchers can compare DOC-treated versus control samples to define the response signature and then annotate differentially expressed genes to GO:1903496.
Endocrine challenge tests
Because the DOC response is regulated by ACTH, insulin, sodium intake, and furosemide, challenge tests are valuable. Studies in normal man and hypertensive patients have measured 18-hydroxy-11-deoxycorticosterone after ACTH, insulin, and furosemide administration. Low sodium intake enhances sensitivity to ACTH, providing a dietary challenge paradigm. These methods quantify the dynamic regulation of the DOC axis.
Electrolyte and urinary assays
Urine electrolyte response to 18-hydroxy-11-deoxycorticosterone in normal man provides a direct physiological readout of the DOC response. Urinary kallikrein measurement in Dahl salt-sensitive rats after deoxycorticosterone treatment links the response to renal enzyme secretion. These assays are inexpensive and physiologically anchored.
Immune-endocrine profiling
In Eurasian perch, LPS challenge combined with cortisol or 11-deoxycorticosterone treatment was used to measure immune and endocrine variables, showing that DOC modulates the response to an immune stimulus. This approach can be adapted to mammalian systems to study immune-endocrine crosstalk in the context of GO:1903496.
How CRISPR Can Be Used to Study GO:1903496 response to 11-deoxycorticosterone
Knockout
CRISPR knockout is used to test whether a candidate gene is required for the response to 11-deoxycorticosterone. For example, knocking out NR3C2 or SCNN1A in a relevant cell line followed by DOC treatment and RNA-seq can reveal which transcriptional and electrolyte responses depend on the mineralocorticoid receptor pathway. In vivo knockout in the DOCA-salt model can test causality for hypertension phenotypes. Knockout of stress-responsive genes identified by transcriptomics can validate their role in the DOC response.
Point Mutation
Point-mutation knock-in allows precise testing of residues hypothesized to affect DOC responsiveness. For example, mutations in CYP11B2 or NR3C2 that alter steroid binding or enzyme activity can be introduced to measure changes in DOC metabolism or signaling. This approach is useful when a disease-associated variant is suspected to alter the response to DOC.
Knock-in
Knock-in of reporter genes, tags, or inducible promoters enables visualization and controlled expression of genes involved in the DOC response. A tagged knock-in of a stress-responsive gene can show its localization after DOC treatment. Knock-in of a constitutively active allele can test whether activation of a pathway is sufficient to mimic DOC effects.
Overexpression
CRISPR-mediated overexpression or cDNA overexpression can test whether increased levels of a candidate gene enhance or mimic the DOC response. Overexpressing REN or AGTR1 in the context of DOCA-salt treatment can probe cardiovascular outcomes. Overexpression of immune genes such as IL6 can test immune-endocrine crosstalk observed with DOC.
How EDITGENE Supports response to 11-deoxycorticosterone Research
Researchers studying response to 11-deoxycorticosterone-related genes often need to determine whether a candidate gene is causally involved in the DOC response or merely correlated with it. EDITGENE provides CRISPR-based cell model services that enable loss-of-function, gain-of-function, and precise variant modeling to answer these questions in a controlled experimental system.
Contact EDITGENE today to design your custom CRISPR model for response to 11-deoxycorticosterone research.
Frequently Asked Questions About response to 11-deoxycorticosterone
What is GO:1903496?
GO:1903496 is the Gene Ontology biological_process term for response to 11-deoxycorticosterone, defined as any process that results in a change in state or activity of a cell or organism as a result of an 11-deoxycorticosterone stimulus.
What is 11-deoxycorticosterone?
11-deoxycorticosterone (DOC) is a steroid intermediate in mineralocorticoid and glucocorticoid biosynthesis that can influence electrolyte handling, blood pressure, stress responses, and immune-endocrine crosstalk.
What genes are involved in response to 11-deoxycorticosterone?
Genes implicated include NR3C2, CYP11B1, CYP11B2, POMC, INS, KLK1, SCNN1A, ATP1A1, REN, ACE, AGTR1, and stress-responsive genes such as FOS and JUN, based on physiological and transcriptomic studies.
How is the response to 11-deoxycorticosterone regulated?
It is regulated by ACTH, insulin, sodium intake, furosemide-sensitive pathways, and inflammatory state, as shown in human and animal studies.
What diseases are linked to 11-deoxycorticosterone?
DOC excess is linked to mineralocorticoid hypertension, as modeled by DOCA-salt hypertension, and to salt-sensitive hypertension through anomalous kallikrein responses.
How do researchers study response to 11-deoxycorticosterone?
Common methods include RNA-seq after DOC treatment, ACTH and insulin challenge tests, urine electrolyte and kallikrein assays, LPS immune challenge, and DOCA-salt protocols.
What is the DOCA-salt hypertension model?
DOCA-salt hypertension is an experimental model in which deoxycorticosterone administration combined with high salt intake produces sustained hypertension and cardiovascular changes.
Does 11-deoxycorticosterone affect the immune system?
Yes, in Eurasian perch DOC modulates immune and endocrine responses to LPS, indicating immune-endocrine crosstalk.
Can CRISPR be used to study response to 11-deoxycorticosterone?
Yes, CRISPR knockout, point-mutation knock-in, knock-in, and overexpression models can test causal roles of candidate genes in the DOC response.
What is the difference between 11-deoxycorticosterone and aldosterone?
11-deoxycorticosterone is a precursor steroid, while aldosterone is the principal mineralocorticoid; enzymes such as CYP11B2 act on DOC in aldosterone synthesis.
Conclusion
GO:1903496, response to 11-deoxycorticosterone, provides a standardized framework for annotating the diverse cellular and organismal changes triggered by this steroid. From transcriptional reprogramming in fish muscle to electrolyte handling in humans and DOCA-salt hypertension in rodents, the response process spans molecular, physiological, and pathological scales. Understanding its regulation by ACTH, insulin, sodium, and immune signals is essential for interpreting endocrine and cardiovascular datasets. For researchers, CRISPR-based models offer a direct route to causal inference. By combining knockout, point-mutation, knock-in, and overexpression approaches with transcriptomic and physiological readouts, it is possible to move from correlation to mechanism within the response to 11-deoxycorticosterone. EDITGENE supports this workflow with custom cell model generation and screening services.
References
- 1. Zuloaga R et al.. 2023. Effect of 11-Deoxycorticosterone in the Transcriptomic Response to Stress in Rainbow Trout Skeletal Muscle.. Genes (Basel) 14(2) PMID: 36833439
- 2. Tosti-Croce C et al.. 1981. 18-hydroxy-11-deoxycorticosterone response to ACTH, insulin and furosemide administration in essential hypertensive patients.. Horm Res 15(1):28-36 PMID: 6277757
- 3. Nicholls MG et al.. 1977. Urine electrolyte response to 18-hydroxy-11-deoxycorticosterone in normal man.. Clin Sci Mol Med 53(5):493-8 PMID: 22421
- 4. Mathieu C et al.. 2014. In vivo response of some immune and endocrine variables to LPS in Eurasian perch (Perca fluviatilis, L.) and modulation of this response by two corticosteroids, cortisol and 11-deoxycorticosterone.. Comp Biochem Physiol A Mol Integr Physiol 167:25-34 PMID: 24041989
- 5. Rapp JP et al.. 1982. Anomalous response of urinary kallikrein to deoxycorticosterone in Dahl salt-sensitive rats.. Hypertension 4(1):20-6 PMID: 6916711
- 6. Sparano F et al.. 1978. 18-Hydroxy-11-deoxycorticosterone response to insulin in normal man.. J Steroid Biochem 9(11):1061-3 PMID: 745404
- 7. Kater CE et al.. 1992. Low sodium intake enhances sensitivity of 11-deoxycortisol and deoxycorticosterone to ACTH in ACTH-suppressed normal subjects.. J Steroid Biochem Mol Biol 42(6):617-23 PMID: 1322161
- 8. Schenk J et al.. 1992. The pathogenesis of DOCA-salt hypertension.. J Pharmacol Toxicol Methods 27(3):161-70 PMID: 1498343
